ISRG - Intuitive Surgi Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.89%) NVAX (1.83%) LAKE (4.97%) AGRX (8.77%) AAPL (-0.29%) BAC (-1.7%) PTON (1.47%) LEDS (0%) APT (17.88%) AMRN (-2.61%) AAOI (-1.9%) JPM (-2.49%) JNJ (-0.15%) JEF (-1.09%) IWM (-1.23%) INTC (8.14%) HOME (-0.5%) HEXO (-6%) HAL (-2.04%) GPRO (0.46%) FDX (-0.53%) FB (-0.83%) ENDP (-10.24%) ELOX (-5.55%) DIS (-1.5%)

ISRG - Intuitive Surgical

$589.20 -25.8[-4.2%]

15 mins delayed data

People also watch : HOLX | SNN | BSX | VAR | BDX | MDT

+Watchlist

13 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$615.00	Open	$604.80
Volume	2.09M	Market Cap	55.094B
Yield		Last Dividend

Day

52 Week

Exact Sciences, GameStop, Intel, Intuiti...	01/24/20
Exact Sciences, GameStop, Intel, Intuitive Surgical and Skyworks highlighted as Zacks Bull and Bear of the Day

Intuitive Surgical Shares Slide Despite ...	01/24/20
Analysts are voicing support for Intuitive Surgical after the medical-equipment producer beat Wall Street's earnings expectations, but the shares are ...

Intuitive Surgical down 4% after Q4 repo...	01/24/20
Sell-side analysts weigh in after Intuitive Surgical (ISRG -4.1%) reported Q4 and 2019 results after the close yesterday. Evercore ISI's Vijay Kumar (...

Intuitive Surgical (ISRG) Q4 Earnings To...	01/24/20
Intuitive Surgical (ISRG) gains from solid international show in Q4.

Intuitive Surgical : Beats Wall Street F...	01/23/20
By Micah Maidenberg Intuitive Surgical Inc. reported stronger shipments for its main surgery product in the fourth quarter, a performance that helped ...

Intel, Intuitive, Skyworks All Beat Earn...	01/23/20
Intel, Intuitive Surgical and Skyworks all posted better-than-expected earnings after the bell.

Global Commercial Service Robot Market F...	01/22/20
DUBLIN, Jan. 22, 2020 /PRNewswire/ -- The "Commercial Service Robot Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchA...

What's in the Cards for Intuitive Surgic...	01/20/20
Better-than-expected performance at Instruments & Accessories segment and da Vince procedure growth are likely to have benefited Intuitive Surgical's ...

Intuitive Surgical (ISRG) Up on Solid Pr...	01/10/20
Higher revenues and growth in worldwide da Vinci procedure volume benefit Intuitive Surgical's (ISRG) preliminary Q4 results.

Stocks making the biggest moves after th...	01/09/20
Take a look at the companies making headlines after the bell.

ANALYST RATINGS

7 analyst ratings (Last 6 months)

71.43 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	01/24/20
Raymond James maintains Outperform rating and raises Price Target from $615.00 to $660.00

Strong Buy rating	01/24/20
JP Morgan maintains Overweight rating and raises Price Target from $575.00 to $665.00

Strong Buy rating	01/10/20
and raises Price Target from $620.00 to $690.00

Hold rating	01/10/20
UBS maintains Neutral rating and raises Price Target from $590.00 to $620.00

Strong Buy rating	12/17/19
Morgan Stanley maintains Overweight rating and raises Price Target from $620.00 to $670.00

Buy rating	11/29/19
First Shanghai initiates coverage with Buy rating and announces Price Target of $729.40

Hold rating	10/18/19
UBS maintains Neutral rating and raises Price Target from $560.00 to $590.00

EARNINGS

Date	2020-01-23 (AMC)	Est. (EPS/Rev.)	$3.38/ 1.24B
Actual (EPS/Rev.)	$3.48/ $1.28 B	EPS (TTM)	0

TRADERS TRACKING $ISRG

Service Name	Trader	% Success
Tech Trades	Ravi	91.00 %	Follow
Trading Systems	Trading Systems	83.00 %	Subscribe
The Profit Machine	Gino Baldassano	66.00 %	Subscribe
Spread and Condor Play	Sankar	65.00 %	Subscribe
MA MA MIA	Hao	60.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.